PAHO opens a new pathway to access lenacapavir for HIV prevention in Latin America and the CaribbeanHealth care

Caring patient and health is our expertise.|Through an agreement with Gilead Sciences, the Organization will facilitate access to this innovation in 14 countries through its Regional Revolving Funds, complementing existing voluntary licensing arrangements and supporting a longer-term strategy for

PAHO Org

PAHO opens a new pathway to access lenacapavir for HIV prevention in Latin America and the Caribbean

PAHO opens a new pathway to access lenacapavir for HIV prevention in Latin America and the Caribbean

Through an agreement with Gilead Sciences, the Organization will facilitate access to this innovation in 14 countries through its Regional Revolving Funds, complementing existing voluntary licensing arrangements and supporting a longer-term strategy for sustainable access.Washington, D.C., September 15, 2026 (PAHO) – The Pan American Health…